In partnership with
The Bottom Line Upfront 💡
$KO ( ▲ 0.66% ) Coca-Cola is a royalty business disguised as a beverage company: it owns the recipes and brands while bottlers do the dirty work, generating fortress-like margins. At ~$88, you are paying a fair price for a durable compounder. The one real wildcard is a $14B+ IRS tax overhang.
Sponsorship
Find Out What's Holding Your Revenue Back
Your business didn't plateau overnight. Growth slowed one bottleneck at a time.
But more hours at the office, more hires, and more marketing won't remove a hidden limitation. They just make it harder to spot.
The Revenue Ceiling Report reveals the four most common growth ceilings so you can identify what's quietly costing your business revenue and what to do next.
BELAY’s U.S.-based Assistants help build the systems and support that turn sustainable growth into reality.
Strata Layers Chart
Layer 1: The Business Model 🏛️
Coca-Cola has been selling fizzy happiness since 1886. Today it operates in 200+ countries, delivering 2.2 billion servings per day. That is not a typo.
Here is the clever part: Coke does not actually make most of its beverages. It makes the secret recipe concentrate, sells it to independent bottlers, and those bottlers do the heavy lifting of mixing, canning, and trucking product to your local gas station. Think of Coke as the landlord who owns the recipe and collects rent in the form of concentrate sales, while the bottlers run the factories.
This asset-light concentrate model generates fat margins (more on that below). When Coke owns bottling operations directly (the Bottling Investments segment), margins shrink considerably because manufacturing is expensive. The long-term strategy is to refranchise those operations back to independent partners, which is exactly what it has been doing in India and Africa recently.
Key brands you already know: Coca-Cola, Sprite, Fanta, Diet Coke, Coca-Cola Zero Sugar, Dasani, Powerade, BODYARMOR, Minute Maid, Simply, fairlife, and Costa Coffee.
How management measures success:
Unit Case Volume: How many 192-oz cases consumers actually drink (worldwide: 33.8 billion in 2025 ↗️)
Concentrate Sales Volume: How much concentrate Coke ships to bottlers
Price/Mix: Whether Coke is selling more premium products at higher prices
Key Takeaway: Coke is essentially a royalty business disguised as a beverage company. It owns the recipes and the brands. Everyone else does the physical work.
Layer 2: Category Position 🏆
Coke is the undisputed heavyweight champion of non-alcoholic beverages. Trademark Coca-Cola alone represents 47% of worldwide unit case volume. Its top five bottling partners (FEMSA, CCEP, CCHBC, Arca Continental, Swire) handle 44% of global volume, giving Coke a distribution network competitors cannot replicate overnight.
The main rival is PepsiCo, which competes across beverages and snacks. Other challengers include Keurig Dr Pepper, Nestlé, Danone, and Red Bull. Increasingly, Coke also faces scrappy microbrands selling direct-to-consumer online, the beverage equivalent of fighting a thousand tiny fires simultaneously.
Where Coke is winning: Asia Pacific unit case volume grew +7-8% in H1 2026 ↗️, led by India (+13% in Q2). Latin America is also strong, with Colombia up 20% and Peru up 16% in Q2.
Where it is trickier: Asia Pacific operating margin compressed to 40.9% from 45.6% ↘️ because of affordability pricing initiatives and higher commodity costs. You cannot charge Tokyo prices in every market.
The BODYARMOR sports drink acquisition (2021) has been a headache. Coke took a $960 million impairment charge on the trademark in late 2025 due to a slowing projected long-term growth rate and an intensifying competitive environment. Translation: Gatorade (PepsiCo) is tough to dislodge.
Key Takeaway: Coke's global distribution moat is genuinely enormous, but it is not immune to category-level competition, especially in faster-growing segments like sports drinks.
Layer 3: Show Me The Money! 📈
Revenue breakdown (H1 2026, $25.9B total) ↗️ +9%:
Segment | Revenue | Growth |
|---|---|---|
North America | $10.3B | +10% ↗️ |
EMEA | $6.3B | +7% ↗️ |
Latin America | $3.5B | +15% ↗️ |
Asia Pacific | $3.1B | +3% ↗️ |
Bottling Investments | $3.2B | +10% ↗️ |
Revenue growth came from three sources: volume (+6%), pricing (+2%), and favorable currency (+2%), partially offset by divestitures (-1%). A healthy, balanced mix.
Margins are expanding: Gross margin hit 62.9% ↗️ (up from 62.5%). Operating margin reached 34.9% ↗️. Latin America is the profit star at a 63% operating margin. Yes, 63%. The concentrate model in emerging markets is extraordinarily profitable.
The cash flow story needs context. Reported operating cash flow swung from -$1.4B in H1 2025 to +$7.5B in H1 2026 ↗️. But H1 2025 was distorted by the $6.17B final milestone payment for the fairlife acquisition. Normalized free cash flow is roughly $11-12B annually, not the $5B the reported numbers suggest. This distinction matters enormously for valuation.
Advertising spend jumped to $2.9B in H1 2026 ↗️ (+22%), aggressive but consistent with Coke's brand-first strategy.
Dividend: $4.56B paid in H1 2026 alone. The quarterly dividend is $0.53/share, annualizing to $2.12. Coke has raised its dividend for 63 consecutive years. It is basically a law of nature at this point.
Key Takeaway: Coke's financial engine is humming, with expanding margins and strong volume growth globally, but you need to normalize for one-time items to see the true cash generation power.
Layer 4: Long-Term Valuation (DCF Model) 💰
The Verdict: Fairly Valued to Modestly Undervalued
Scenario | Fair Value | vs Current Price (~$88) |
|---|---|---|
Conservative | $85 | -3% |
Base Case | $95 | +8% |
Bull Case | $137 | +56% |
Bear Case | $65 | -26% |
Key assumptions:
Normalized FCF of ~$11-12B annually (stripping out the fairlife and IRS one-time payments)
WACC of 6.3-6.5% (Coke's beta is a remarkably low 0.34, making it one of the least volatile large-cap stocks)
Terminal growth rate of 2.5-3.5%
One valuation service pegs Coke at ~$52, which looks alarming until you realize it is using reported (distorted) cash flows and a 9% discount rate for a company with a 0.34 beta. That is like penalizing a minivan for not being a sports car.
One-line take: At ~$88, you are paying a fair price for one of the world's most durable businesses, with modest upside if emerging markets continue to accelerate.
Layer 5: What Do We Have to Believe? 📚
Bull Case 🚀
Asia Pacific and Latin America sustain mid-to-high single-digit volume growth, driven by rising middle-class consumption in India, China, and Brazil
fairlife and Coca-Cola Zero Sugar continue gaining share, proving Coke can win in premium and health-adjacent categories
The IRS tax litigation resolves favorably, avoiding up to $14B in additional liability (a massive overhang that disappears if Coke wins on appeal)
Bear Case 🐻
The IRS wins on appeal: potential $14B+ in additional taxes for 2010-2025 would be a serious financial hit, even for a company this size
Consumer health trends accelerate away from sugary beverages faster than Coke can pivot its portfolio (BODYARMOR's struggles are a cautionary tale)
A sustained strong U.S. dollar crushes international earnings (84% of volume is outside the U.S., so currency matters a lot)
The Bottom Line: Coke is the definition of a sleep-well-at-night stock. It has raised its dividend for 63 straight years, generates enormous cash flow, and sells products that people buy regardless of economic conditions. The IRS litigation is the one genuine wildcard that deserves attention. At ~$88, you are not getting a screaming bargain, but you are buying a fortress business at a reasonable price.
Layer 6: What to Watch 👀
IRS Litigation Ruling: The U.S. Court of Appeals for the Eleventh Circuit heard arguments in June 2026. A ruling against Coke could mean $14B+ in additional taxes. Watch for any court updates.
BODYARMOR Recovery: Management flagged the trademark is now at fair value after the $960M impairment. If near-term results miss revised projections, another impairment charge is possible.
Asia Pacific Margin: Volume is booming (+7-8%) but margins compressed to 40.9% ↘️. Watch whether affordability pricing is a temporary investment or a structural margin headwind.
fairlife Post-Ransomware: A July 2026 ransomware attack temporarily halted production. Management says it is not material, but fairlife is a key growth asset. Monitor for any lingering supply or reputational impact.
Africa Bottling Sale Closing: The deal with CCHBC is expected to close by end of 2026. Successful execution cleans up the balance sheet and reduces complexity.
AI-written, human-approved
Disclaimer: This guide is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer or solicitation to buy or sell any securities. The information contained in this report has been obtained from sources believed to be reliable, but StrataFinance does not guarantee its accuracy, completeness, or timeliness.